Nissay Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $108M | Buy |
494,825
+64,026
| +15% | +$14.2M | 0.57% | 34 |
|
|
2025
Q4 | $98.4M | Buy |
430,799
+205,806
| +91% | +$46.9M | 0.51% | 37 |
|
|
2025
Q3 | $52.1M | Buy |
224,993
+1,596
| +0.7% | +$325K | 0.29% | 58 |
|
|
2025
Q2 | $41.5M | Sell |
223,397
-286
| -0.1% | -$53.2K | 0.24% | 68 |
|
|
2025
Q1 | $46.9M | Buy |
223,683
+1,943
| +0.9% | +$378K | 0.3% | 58 |
|
|
2024
Q4 | $39.5M | Buy |
221,740
+2,103
| +1% | +$387K | 0.24% | 64 |
|
|
2024
Q3 | $43.4M | Buy |
219,637
+2,636
| +1% | +$492K | 0.27% | 58 |
|
|
2024
Q2 | $37.2M | Buy |
217,001
+5,767
| +3% | +$955K | 0.25% | 63 |
|
|
2024
Q1 | $38.5M | Buy |
211,234
+183
| +0.1% | +$31.5K | 0.27% | 57 |
|
|
2023
Q4 | $32.7M | Sell |
211,051
-557
| -0.3% | -$81.2K | 0.26% | 60 |
|
|
2023
Q3 | $31.5M | Buy |
211,608
+2,031
| +1% | +$298K | 0.28% | 56 |
|
|
2023
Q2 | $28.2M | Sell |
209,577
-9,305
| -4% | -$1.36M | 0.24% | 60 |
|
|
2023
Q1 | $34.9M | Sell |
218,882
-7,571
| -3% | -$1.16M | 0.31% | 58 |
|
|
2022
Q4 | $36.6M | Sell |
226,453
-6,215
| -3% | -$953K | 0.35% | 55 |
|
|
2022
Q3 | $31.2M | Buy |
232,668
+7,337
| +3% | +$1.05M | 0.33% | 54 |
|
|
2022
Q2 | $34.5M | Buy |
225,331
+9,492
| +4% | +$1.45M | 0.34% | 47 |
|
|
2022
Q1 | $35M | Buy |
215,839
+3,708
| +2% | +$539K | 0.3% | 55 |
|
|
2021
Q4 | $28.7M | Buy |
212,131
+5,143
| +2% | +$608K | 0.22% | 71 |
|
|
2021
Q3 | $22.3M | Buy |
206,988
+11,593
| +6% | +$1.32M | 0.19% | 80 |
|
|
2021
Q2 | $22M | Sell |
195,395
-26,188
| -12% | -$2.95M | 0.19% | 83 |
|
|
2021
Q1 | $24M | Sell |
221,583
-4,325
| -2% | -$463K | 0.24% | 74 |
|
|
2020
Q4 | $24.2M | Buy |
225,908
+29,528
| +15% | +$2.84M | 0.36% | 66 |
|
|
2020
Q3 | $17.2M | Sell |
196,380
-21,298
| -10% | -$2.01M | 0.29% | 78 |
|
|
2020
Q2 | $21.4M | Buy |
217,678
+48,568
| +29% | +$4.28M | 0.41% | 65 |
|
|
2020
Q1 | $12.9M | Buy |
169,110
+6,993
| +4% | +$596K | 0.33% | 82 |
|
|
2019
Q4 | $14.4M | Sell |
162,117
-1,131
| -0.7% | -$93.9K | 0.32% | 84 |
|
|
2019
Q3 | $12.4M | Buy |
163,248
+4,159
| +3% | +$285K | 0.3% | 81 |
|
|
2019
Q2 | $11.6M | Sell |
159,089
-1,190
| -0.7% | -$93.5K | 0.29% | 86 |
|
|
2019
Q1 | $12.9M | Sell |
160,279
-7,365
| -4% | -$603K | 0.34% | 72 |
|
|
2018
Q4 | $15.5M | Sell |
167,644
-6,336
| -4% | -$557K | 0.47% | 46 |
|
|
2018
Q3 | $16.5M | Sell |
173,980
-6,075
| -3% | -$576K | 0.44% | 52 |
|
|
2018
Q2 | $16.7M | Buy |
180,055
+1,357
| +0.8% | +$133K | 0.49% | 45 |
|
|
2018
Q1 | $16.9M | Sell |
178,698
-21,408
| -11% | -$2.35M | 0.53% | 44 |
|
|
2017
Q4 | $19.4M | Buy |
+200,106
| New | +$18.9M | 0.59% | 41 |
|
Other funds holding ABBV
VCM
VPM
Nissay Asset Management's ABBV Position: Q1 2026 in Review
Nissay Asset Management increased its AbbVie (ABBV) stake by 15% in Q1 2026, buying an estimated $14.2M and bringing the position to 494,825 shares worth $108M. The position accounts for 0.57% of the portfolio, ranked #34.
Nissay Asset Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Nissay Asset Management held 494,825 shares of AbbVie worth $108M as of Q1 2026.
- Nissay Asset Management bought 64,026 AbbVie shares in Q1 2026, an estimated $14.2M.
- AbbVie made up 0.57% of Nissay Asset Management's portfolio in Q1 2026, its #34 holding.
- Nissay Asset Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Nissay Asset Management's 13F filing for Q1 2026, filed 15 May 2026.